Saturday, 31 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Results Correction

Alkem Laboratories Results Correction

Alkem Laboratories Limited submitted revised XBRL financial results for the quarter ended March 31, 2025, following a clarification request from the National Stock Exchange. The revision addresses discrepancies regarding the 'audited' status of the results. This is a administrative correction to ensure regulatory compliance.

Source

NSE filing, NSE: ALKEM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Alkem Laboratories Ltd: key numbers

Share price
₹5,113.50
Market cap
₹61,140 Cr
Revenue (annual)
₹14,712 Cr
Net profit (annual)
₹2,302 Cr
P/E (TTM)
28.3×Sector 45.9×
Promoter holding
49.70%+0.00% QoQ
FII holding
10.32%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Alkem Laboratories Ltd

All →

Other results correction announcements

All →